RDGL Projected Dividend Yield
Vivos Inc ( OTCBB : RDGL )Vivos is a radiation oncology medical device company engaged in the development of its yttrium-90 based brachytherapy device, RadioGel™, for the treatment of non-resectable tumors. RadioGel™ is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. RadioGel™ is comprised of a hydrogel, or a substance that is liquid at room temperature and then gels when reaching body temperature after injection into a tumor. Co.'s main brachytherapy products, including RadioGel™, incorporate patented technology developed for Battelle Memorial Institute at Pacific Northwest National Laboratory, a research institute for government and commercial customers. 20 YEAR PERFORMANCE RESULTS |
RDGL Dividend History Detail RDGL Dividend News RDGL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |